raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:401805

Autosomal recessive spastic paraplegia type 63

Synonyms: SPG63

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

Autosomal recessive spastic paraplegia type 63 (SPG63) is an extremely rare and complex form of hereditary spastic paraplegia characterized by an onset in infancy of spastic paraplegia (presenting with delayed walking and a scissors gait) associated with short stature, and normal cognition. Periventricular deep white matter changes in the corpus callosum are noted on brain imaging. SPG63 is caused by a homozygous mutation in the <i>AMPD2</i> gene (1p13.3) encoding AMP deaminase 2.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal recessive spastic paraplegia type 63SPG63
frParaplégie spastique autosomique récessive type 63= en
deSpastische Paraplegie, autosomal-rezessive, Typ 63= en
esParaplejía espástica autosómica recesiva tipo 63= en
itParaplegia spastica autosomica recessiva, tipo 63= en
nlAutosomaal recessieve spastische paraplegie type 63= en
ptParaplegia espástica autossómica recessiva tipo 63
plAutosomalna recesywna paraplegia spastyczna typu 63= en
csAutozomálně recesivní spastická paraplegie, typ 63= en
ukАутосомно-рецесивна спастична параплегія, тип 63= en
zh常染色体隐性遗传痉挛性截瘫63型= en
trOtozomal resesif spastik parapleji tip 63= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM615686Evalidated
ICD-10G11.4NTBTattributedvalidated
ICD-118B44.01NTBTattributedvalidated
MONDO0014305Evalidated
UMLSC3810295Evalidated
GARD17658Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
AMPD2Disease-causing germline mutation(s) inAssessedHGNC:469ENSG000001163371027711p13.3adenosine monophosphate deaminase 224482476[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families2 casesWorldwideCase(s)Validated24482476[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_24482476[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

9 annotations · validated 2018-02-06
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0004325Decreased body weight
HP:0002194Delayed gross motor development
HP:0001347Hyperreflexia
HP:0001276Hypertonia
HP:0012407Scissor gait
HP:0004322Short stature
HP:0003202Skeletal muscle atrophy
HP:0001257Spasticity
Occasional (29-5%)
HP:0002518Abnormal periventricular white matter morphology

Annotation source: 24482476[PMID]

7

Sources for this card